As Supernus’ top drug inches toward the patent cliff, the central nervous system-focused drugmaker has struck an M&A deal to quickly expand its portfolio of marketed medicines. In a $ 400 million buyout, Supernus is paying $ 8.10 per share to buy CNS drugmaker Adamas Pharmaceuticals. With the deal, Supernus gets rights to Gocovri, the first and only… Read More »
The Biden administration’s call to waive patent rights for coronavirus vaccines sparked vociferous opposition from drugmakers and pharma industry groups, which quickly claimed the move will discourage future drug research and do little to increase supply. Activists, who have pressured the administration for months on the issue, argue a waiver is needed to begin removing… Read More »
The difficulty of learning the technology behind mRNA vaccines poses a major obstacle to President Joe Biden’s proposal aiding poor countries by defying the pharmaceutical industry and waiving patent protections for COVID-19 vaccines. The rationale for the patent waiver would be to allow developing countries to reproduce currently existing COVID-19 vaccines without having to worry… Read More »
The differences can save real money—and headaches. Herbal therapy can strengthen the system. Adams’ New Columbian Rail Road Atlas and Pictorial Album of American Industry. Patents may come in other forms such as dripping pills, liquids, syrups, powders, granules, instant teas, and capsules. Actually they can be taken to reduce the side effects of other… Read More »
Bloomberg—Apple is accused of stealing trade secrets and improperly using Masimo inventions related to health monitoring in its Apple Watch. Masimo, which develops signal processing technology for healthcare monitors, and its spinoff, Cercacor Laboratories, claim in a lawsuit that Apple got secret information under the guise of a working relationship and then hired away key… Read More »